85W-22852-25017
3 vaccinations
12 coded responses
31 check-ins
12 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 582 / ND
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-20
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Registered in v-safe
-
2021-01-21
Survey response — days 1–6 daily, dose 1MedDRA: Myasthenic syndrome — Feeling: Poor · Site: Pain · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Increase in what resemble myasthenia gravis symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Survey response — days 1–6 daily, dose 1MedDRA: Muscular weakness — Feeling: Fair · Chills, Headache, Joint painsFree text: Increased myasthenia muscle weeknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-23
Survey response — days 1–6 daily, dose 1MedDRA: Muscular weakness — Feeling: Fair · Site: Itching · Joint pains, Fatigue or tirednessFree text: Muscle weakness moderateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-24
- 2021-01-25
- 2021-01-27
- 2021-02-03
-
2021-02-10
Dose 2 — Pfizer-BioNTech
- 2021-02-10
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
-
2021-02-14
Survey response — days 1–6 daily, dose 2MedDRA: Myasthenia gravis, Pre-existing disease — Feeling: Good · Site: Pain · Joint pains, Fatigue or tirednessFree text: Have myasthenia gravis muscle seem to be weaker after both injectionsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-02-16
-
2021-02-17
Survey response — day 7, dose 2MedDRA: Cough, Sneezing — Feeling: Fair · Headache, Joint pains, Fatigue or tirednessFree text: Few sneezes ,coughsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-24
- 2021-03-03
-
2021-03-10
Survey response — day 28, dose 2MedDRA: Diabetes mellitus, Mood altered, Oropharyngeal pain — Feeling: FairFree text: Diabetic flucation, mood, sore throstMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
-
2021-03-24
Survey response — day 42, dose 2MedDRA: Pruritus — Feeling: GoodFree text: ItchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Survey response — 3 months, dose 2MedDRA: Rash, Specialist consultation — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Rash · Healthcare visit (other): Office visit with primary DrMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-11
-
2021-09-20
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-09-30
Health check-in — day 7, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-04
-
2021-10-11
Survey response — day 21, dose 3MedDRA: Unevaluable event — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Joint & muscleMedDRA releases: 2024-11 · check-in free text available
-
2021-10-18
Survey response — day 28, dose 3MedDRA: Arthralgia, Myalgia — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Muscle joint painMedDRA releases: 2024-11 · check-in free text available
-
2021-10-25
Survey response — day 35, dose 3MedDRA: Muscle discomfort, Musculoskeletal discomfort — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Joint, muscle discomfortMedDRA releases: 2024-11 · check-in free text available
- 2021-11-01
-
2021-12-22
Survey response — 3 months, dose 3MedDRA: Blood glucose decreased, Pre-existing disease — Feeling: FairFree text: Low blood sugars, normally high bs is issue. Even when holiday food carbsMedDRA releases: 2024-11 · check-in free text available
- 2022-03-21
- 2022-04-15
- 2022-04-20
-
2022-04-20
Call successfulParticipant prefers to complete VAERS report online
- 2022-09-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Pfizer-BioNTech | |
| 2 | 2021-02-10 | Pfizer-BioNTech | |
| 3 | 2021-09-20 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
1 wait over 3 months for a first call
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Increase in what resemble myasthenia gravis symptoms
Systemic reaction (other): Increased myasthenia muscle weekness
Systemic reaction (other): Muscle weakness moderate
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Have myasthenia gravis muscle seem to be weaker after both injections
Release 4 — day 7, dose 2
Systemic reaction (other): Few sneezes ,coughs
Release 5 — day 28, dose 2
Symptoms: Diabetic flucation, mood, sore throst
Release 6 — day 42, dose 2
Symptoms: Itch
Release 8 — 3 months, dose 2
Release 10 — day 21, dose 3
Symptoms: Joint & muscle
Release 10 — day 28, dose 3
Symptoms: Muscle joint pain
Release 10 — day 35, dose 3
Symptoms: Joint, muscle discomfort
Release 10 — 3 months, dose 3
Symptoms: Low blood sugars, normally high bs is issue. Even when holiday food carbs
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Specialist consultation | ✓ | ✓ | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Blood glucose decreased | · | · | ✓ |
| SD | Diabetes mellitus | ✓ | ✓ | ✓ |
| SD | Mood altered | ✓ | ✓ | ✓ |
| SD | Muscle discomfort | · | · | ✓ |
| SD | Musculoskeletal discomfort | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
| SRO | Myasthenia gravis | ✓ | ✓ | ✓ |
| SRO | Myasthenic syndrome | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release